Patient Access Expansion EmVenio specializes in community-based sites and mobile research services to expand trial access and diversify participant pools. This positions them to pursue partnerships with sponsors seeking faster enrollment and more representative data across regions.

Global Reach, Local Reach With operations in the U.S. and Europe and a large network of professionals supporting trials in over 80 countries, there are opportunities to upsell end-to-end trial services, patient recruitment, and site management to international sponsors seeking scale with localized execution.

Patient Navigator Opportunity Recent launches of Patient Navigator offerings target logistical and financial barriers to participation, creating a compelling upsell path for sponsors needing patient retention tools, patient support programs, and value-added services to improve trial adherence.

Awarded Credibility Industry recognition as Best Clinical Trial Company at Vaccine Industry Excellence Awards enhances competitive positioning, making it easier to engage sponsors and CROs looking for proven partners with a track record of quality and reliability.

Mid-market Growth Potential With revenue in the mid single-digit tens of millions and a strong emphasis on speed, data quality, and inclusive study designs, EmVenio is well-suited to target mid-market sponsors and growing biotech companies seeking scalable, patient-centric trial solutions.